BRIEF-Valeant says cannot comment on or speculate about possible course of any ongoing investigation
Aug 10 (Reuters) - Valeant Pharmaceuticals International Inc
* Cannot comment on or speculate about possible course of any ongoing investigation
* Previously disclosed in Oct 2015 that U.S. attorney's office for SDNY commenced investigation involving co
* Comments on SDNY investigation
* Statement on ongoing investigation being conducted by U.S. attorney's office for southern district of New York Source text for Eikon: Further company coverage:
© Thomson Reuters 2017 All rights reserved.